Intravenous Laser Blood Irradiation and Tocilizumab in a Patient with Juvenile Arthritis
This study presents effects of intravenous laser blood irradiation (ILBI) in a transient immunodeficiency patient with juvenile idiopathic arthritis (JIA) treated with an interleukin-6 receptor inhibitor (Tocilizumab). Biological agents induce JIA remission, but some patients do not respond favorabl...
Saved in:
Main Authors: | Dragos Andrei Chiran, Michael Weber, Laura Marinela Ailioaie, Eovelina Moraru, Constantin Ailioaie, Daniela Litscher, Gerhard Litscher |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/923496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Laser Therapy and Dementia: A Database Analysis and Future Aspects on LED-Based Systems
by: Daniela Litscher, et al.
Published: (2014-01-01) -
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study
by: Patrice Cacoub, et al.
Published: (2023-06-01) -
Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis
by: Takuya Izumiyama, et al.
Published: (2020-01-01) -
Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients
by: Iván Ferraz-Amaro, et al.
Published: (2025-01-01) -
Atherosclerosis in Juvenile Idiopathic Arthritis
by: Ewa Jednacz, et al.
Published: (2012-01-01)